News Archive - Page 51 of 113 - Life Sciences Scotland

Clear

MGB Biopharma – FDA and Health Canada Clear IND/CTA Applications for MGB-BP-3, a Novel, Potent Bactericidal Antibiotic Targeting Clostridium difficile-Associated Diarrhoea (CDAD)

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance, announces...

24th Jan 2019

Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of services for new biological...

23rd Jan 2019

£250K Grant to Fund ‘Game-changing’ Immunotherapy Research for Prostate Cancer

Researchers from the University of Glasgow have received a grant worth over £250,000 from health charity, Prostate Cancer UK, to explore...

22nd Jan 2019

Millions of osteoporosis sufferers could be helped by Strathclyde research project

Researchers at the University of Strathclyde have launched a clinical investigation which could eventually help millions of osteoporosis sufferers by...

22nd Jan 2019

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

TC BioPharm (TCB), a developer of CAR-T immuno-oncology products, including Gamma Delta T (GDT) cell therapies, today announced it has...

22nd Jan 2019

Take on the biggest healthcare challenges: apply for funding

UK businesses can apply for a share of up to £10 million to develop technologies, products and processes that could...

17th Jan 2019

Learn About Our Key Subsectors

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News